Senzime shares rise on reaffirmed Q4 positive cash flow target

Senzime, a Swedish medical technology firm, saw its shares rise after management confirmed its target of reaching positive cash flow by Q4 2026. The confirmation is a routine guidance reaffirmation, not a new development, and the market reaction reflects modest positive sentiment. The company's ability to meet the target remains uncertain given its cash burn trajectory.